Genenta Science S.p.A. American Depositary Shares (GNTA) Stock Price, Quote & AI Analysis
Live GNTA stock price, real-time charts, AI-powered trade signals, technical analysis, earnings insights, and market sentiment for Genenta Science S.p.A. American Depositary Shares.
TradeVae provides AI-driven analysis and real-time market intelligence for Genenta Science S.p.A. American Depositary Shares (GNTA), including price action, technical indicators, earnings performance, analyst sentiment, and short-term trade setups.
AI Analysis
Explore comprehensive AI-powered analysis including summary insights, bull and bear cases, key risks, and factors to watch.
Generating AI analysis...
Genenta Science S.p.A. American Depositary Shares's fundamentals reflect its scale, profitability, and position within the global technology sector. Key valuation and financial metrics are summarized below, followed by detailed financial statements.
Genenta Science S.p.A. American Depositary Shares Overview
Company information
Company Overview
Genenta Science SpA is an early-stage company, which engages in the development of first-in-class cell and gene cancer therapies. Its lead product candidate, Temferon, was developed using its platform and carries an interferon-alpha payload. The company was founded by Pierluigi Paracchi, Luigi Naldini and Bernhard Gentner on July 24, 2014 and is headquartered in Milan, Italy.
Company Details
Technical Indicators
Key technical analysis metrics and signals
Loading technical indicators...
Valuation Metrics
Key valuation ratios and comparisons
Loading valuation metrics...
Genenta Science S.p.A. American Depositary Shares Earnings & Financial Statements
Earnings Calendar
Upcoming earnings dates and historical surprises
Loading earnings calendar...
Financial Statements
Income statements, balance sheets, and cash flow
Loading income statements...
Loading balance sheets...
Loading cash flow statements...